IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%

IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% was reported 381 times

IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUSPECTED PRODUCT QUALITY ISSUE 20 0.0109
1 ALLERGIC TRANSFUSION REACTION 1 0.0066
2 BLOOD INSULIN DECREASED 1 0.0065
3 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
4 VASCULAR ACCESS SITE COMPLICATION 1 0.0040
5 PRODUCT CLOSURE ISSUE 2 0.0036
6 TRANSFUSION REACTION 2 0.0023
7 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0019
8 MEASLES 1 0.0019
9 HELICOBACTER TEST POSITIVE 1 0.0018
10 OCCIPITAL NEURALGIA 1 0.0018
11 PRECANCEROUS CONDITION 1 0.0015
12 INFUSION SITE URTICARIA 1 0.0015
13 FACIAL DISCOMFORT 1 0.0014
14 CROUP INFECTIOUS 1 0.0013
15 PHARYNGEAL PARAESTHESIA 2 0.0013
16 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
17 RECALLED PRODUCT 2 0.0012
18 INTUSSUSCEPTION 1 0.0010
19 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
20 EPSTEIN-BARR VIRAEMIA 1 0.0009
21 MENINGITIS ASEPTIC 4 0.0009
22 BILE DUCT CANCER 1 0.0008
23 WHITE MATTER LESION 1 0.0008
24 FRACTURED COCCYX 1 0.0008
25 BILIARY OBSTRUCTION 1 0.0008
26 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
27 SLEEP PARALYSIS 1 0.0007
28 APRAXIA 1 0.0007
29 KNEE DEFORMITY 1 0.0007
30 MENTAL FATIGUE 1 0.0007
31 INTELLECTUAL DISABILITY 1 0.0007
32 INFUSION RELATED REACTION 42 0.0006
33 URTICARIA 103 0.0006
34 LIP SWELLING 19 0.0006
35 OPHTHALMIC HERPES ZOSTER 1 0.0006
36 HYPOREFLEXIA 1 0.0005
37 EYELID PAIN 1 0.0005
38 INFUSION SITE BRUISING 1 0.0005
39 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
40 DIABETIC COMPLICATION 1 0.0004
41 CATHETER SITE PAIN 1 0.0004
42 AREFLEXIA 1 0.0004
43 SKIN WRINKLING 1 0.0004
44 DRUG SCREEN FALSE POSITIVE 1 0.0004
45 MOUTH SWELLING 2 0.0003
46 CENTRAL VENOUS CATHETERISATION 1 0.0003
47 INFUSION SITE SWELLING 2 0.0003
48 ORTHOPNOEA 1 0.0003
49 EAR PRURITUS 1 0.0003
50 HANGOVER 1 0.0003
51 CATHETER SITE INFECTION 1 0.0003
52 PARANASAL SINUS DISCOMFORT 1 0.0003
53 FACE INJURY 1 0.0003
54 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
55 EPIGASTRIC DISCOMFORT 1 0.0003
56 INTRACRANIAL ANEURYSM 1 0.0002
57 VITAMIN B12 DEFICIENCY 1 0.0002
58 SPINAL STENOSIS 1 0.0002
59 INFUSION SITE ERYTHEMA 2 0.0002
60 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
61 RASH ERYTHEMATOUS 11 0.0002
62 TONGUE DISCOLOURATION 1 0.0002
63 INTERCEPTED MEDICATION ERROR 1 0.0002
64 YELLOW SKIN 1 0.0002
65 RECALLED PRODUCT ADMINISTERED 2 0.0002
66 PARAESTHESIA ORAL 3 0.0002
67 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
68 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
69 PRURITUS 78 0.0002
70 PANCREATIC DISORDER 1 0.0002
71 HYPOAESTHESIA ORAL 3 0.0002
72 PETIT MAL EPILEPSY 1 0.0002
73 POOR VENOUS ACCESS 2 0.0002
74 BRAIN FOG 3 0.0002
75 THROAT TIGHTNESS 5 0.0002
76 SWELLING FACE 12 0.0002
77 AUTISM SPECTRUM DISORDER 1 0.0002
78 PERIORBITAL SWELLING 1 0.0002
79 SCAB 2 0.0002
80 HEART RATE DECREASED 6 0.0002
81 SWELLING OF EYELID 1 0.0002
82 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
83 PRODUCT PREPARATION ISSUE 1 0.0002
84 POSTOPERATIVE WOUND INFECTION 1 0.0001
85 MASS 2 0.0001
86 PAPULE 1 0.0001
87 RETCHING 3 0.0001
88 METASTASIS 1 0.0001
89 PRODUCT SUPPLY ISSUE 1 0.0001
90 UTERINE LEIOMYOMA 1 0.0001
91 ARTHROPOD BITE 1 0.0001
92 RASH PAPULAR 3 0.0001
93 INSURANCE ISSUE 2 0.0001
94 RASH 57 0.0001
95 MIGRAINE 12 0.0001
96 MYASTHENIA GRAVIS 1 0.0001
97 FRUSTRATION TOLERANCE DECREASED 1 0.0001
98 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
99 SENSATION OF FOREIGN BODY 1 0.0001
100 PRODUCT CONTAINER ISSUE 1 0.0001
101 IMMUNOSUPPRESSION 1 0.0001
102 ANAPHYLACTIC REACTION 6 0.0001
103 FLANK PAIN 1 0.0001
104 PHOTOPHOBIA 2 0.0001
105 PRODUCT PACKAGING ISSUE 1 0.0001
106 CHILLS 12 0.0001
107 PHARYNGEAL SWELLING 1 0.0001
108 INABILITY TO AFFORD MEDICATION 1 0.0001
109 MOTOR DYSFUNCTION 1 0.0001
110 CHEST DISCOMFORT 10 0.0001
111 TENDERNESS 1 0.0001
112 WEIGHT FLUCTUATION 1 0.0001
113 SCRATCH 1 0.0001
114 RENAL PAIN 1 0.0001
115 ERYTHEMA 19 0.0001
116 RASH PRURITIC 5 0.0001
117 NEOPLASM 1 0.0001
118 BLOOD IRON DECREASED 1 0.0001
119 CYTOPENIA 1 0.0001
120 PEMPHIGUS 1 0.0001
121 SECRETION DISCHARGE 1 0.0001
122 BLOOD PRESSURE INCREASED 12 0.0001
123 ROTATOR CUFF SYNDROME 1 0.0001
124 OFF LABEL USE 67 0.0001
125 ADVERSE REACTION 1 0.0001
126 EAR INFECTION 2 0.0001
127 SINUS CONGESTION 1 0.0001
128 UVEITIS 1 0.0001
129 PERIPHERAL COLDNESS 1 0.0001
130 RESPIRATORY DISTRESS 2 0.0001
131 FEELING COLD 2 0.0001
132 DEVICE OCCLUSION 1 0.0001
133 BLINDNESS UNILATERAL 1 0.0001
134 HEPATOCELLULAR INJURY 1 0.0001
135 LETHARGY 4 0.0001
136 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
137 BONE LOSS 1 0.0001
138 HEADACHE 41 0.0001
139 DEVICE RELATED INFECTION 1 0.0001
140 PRODUCTIVE COUGH 3 0.0001
141 CONTUSION 6 0.0001
142 BLOOD POTASSIUM INCREASED 1 0.0001
143 MULTIPLE FRACTURES 1 0.0001
144 PHOTOSENSITIVITY REACTION 1 0.0001
145 CHEST PAIN 11 0.0001
146 FLUSHING 6 0.0001
147 COLD SWEAT 1 0.0001
148 ISCHAEMIC STROKE 1 0.0001
149 ADVERSE DRUG REACTION 5 0.0001
150 PELVIC PAIN 1 0.0001
151 TREMOR 9 0.0001
152 BLOOD GLUCOSE ABNORMAL 1 0.0001
153 HYPERSENSITIVITY 10 0.0001
154 EYE SWELLING 2 0.0001
155 UNEVALUABLE EVENT 4 0.0001
156 DYSPHAGIA 5 0.0001
157 BLOOD URINE PRESENT 1 0.0001
158 ERUCTATION 1 0.0001
159 EAR PAIN 1 0.0001
160 BONE PAIN 3 0.0001
161 SPINAL FRACTURE 1 0.0000
162 PRODUCT ADMINISTRATION ERROR 1 0.0000
163 SINUSITIS 5 0.0000
164 INFLUENZA LIKE ILLNESS 4 0.0000
165 TOOTH LOSS 1 0.0000
166 BACK PAIN 11 0.0000
167 JOINT INJURY 1 0.0000
168 RHINORRHOEA 3 0.0000
169 PRODUCT PRESCRIBING ISSUE 1 0.0000
170 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
171 SNEEZING 1 0.0000
172 THROAT IRRITATION 2 0.0000
173 NAUSEA 35 0.0000
174 PRODUCT QUALITY ISSUE 6 0.0000
175 FATIGUE 34 0.0000
176 TINNITUS 2 0.0000
177 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
178 BURNING SENSATION 3 0.0000
179 OCULAR HYPERAEMIA 2 0.0000
180 LOCALISED INFECTION 1 0.0000
181 LUNG DISORDER 2 0.0000
182 INJECTION SITE URTICARIA 1 0.0000
183 THERAPY CESSATION 2 0.0000
184 ILLNESS 4 0.0000
185 ANAPHYLACTIC SHOCK 1 0.0000
186 DIPLOPIA 1 0.0000
187 MUSCLE SPASMS 7 0.0000
188 JOINT STIFFNESS 1 0.0000
189 PROCEDURAL PAIN 1 0.0000
190 HAEMOPTYSIS 1 0.0000
191 NECK PAIN 2 0.0000
192 BLISTER 2 0.0000
193 PAIN IN JAW 1 0.0000
194 MYALGIA 6 0.0000
195 HYPERSOMNIA 1 0.0000
196 HERPES ZOSTER 2 0.0000
197 DYSPHONIA 2 0.0000
198 NASAL CONGESTION 2 0.0000
199 PSYCHOTIC DISORDER 1 0.0000
200 APHASIA 1 0.0000
201 LACRIMATION INCREASED 1 0.0000
202 EPILEPSY 1 0.0000
203 INJECTION SITE RASH 1 0.0000
204 OROPHARYNGEAL PAIN 3 0.0000
205 SWOLLEN TONGUE 1 0.0000
206 DYSPNOEA 18 0.0000
207 GAIT DISTURBANCE 6 0.0000
208 EYE DISORDER 1 0.0000
209 BLOOD PRESSURE DECREASED 2 0.0000
210 EXPIRED PRODUCT ADMINISTERED 1 0.0000
211 EYE PRURITUS 1 0.0000
212 FEELING ABNORMAL 7 0.0000
213 ABDOMINAL PAIN UPPER 6 0.0000
214 ABDOMINAL DISTENSION 3 0.0000
215 RASH MACULAR 1 0.0000
216 COUGH 8 0.0000
217 LYMPHADENOPATHY 1 0.0000
218 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
219 DIZZINESS 14 0.0000
220 THERAPY INTERRUPTED 2 0.0000
221 PANIC ATTACK 1 0.0000
222 UNDERDOSE 2 0.0000
223 ACCIDENTAL OVERDOSE 1 0.0000
224 INJECTION SITE MASS 1 0.0000
225 ASTHMA 3 0.0000
226 INTESTINAL OBSTRUCTION 1 0.0000
227 PYREXIA 9 0.0000
228 PALPITATIONS 3 0.0000
229 PARAESTHESIA 4 0.0000
230 DISORIENTATION 1 0.0000
231 INJECTION SITE BRUISING 2 0.0000
232 CONFUSIONAL STATE 4 0.0000
233 BLINDNESS 1 0.0000
234 LUNG NEOPLASM MALIGNANT 1 0.0000
235 OSTEOPOROSIS 1 0.0000
236 ABDOMINAL DISCOMFORT 4 0.0000
237 HYPOACUSIS 1 0.0000
238 DEVICE DISLOCATION 1 0.0000
239 PRODUCT STORAGE ERROR 2 0.0000
240 MUSCULOSKELETAL STIFFNESS 2 0.0000
241 COVID-19 4 0.0000
242 GASTROINTESTINAL DISORDER 2 0.0000
243 DEVICE ISSUE 2 0.0000
244 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
245 NEPHROLITHIASIS 1 0.0000
246 SKIN DISCOLOURATION 1 0.0000
247 RENAL DISORDER 1 0.0000
248 COGNITIVE DISORDER 1 0.0000
249 SWELLING 2 0.0000
250 NEUROPATHY PERIPHERAL 2 0.0000
251 PRODUCT DOSE OMISSION ISSUE 6 0.0000
252 DYSPEPSIA 2 0.0000
253 HYPOTENSION 4 0.0000
254 INFLAMMATION 1 0.0000
255 HAEMORRHAGE 2 0.0000
256 SPEECH DISORDER 1 0.0000
257 DEPRESSED MOOD 1 0.0000
258 OXYGEN SATURATION DECREASED 1 0.0000
259 FLATULENCE 1 0.0000
260 EYE IRRITATION 1 0.0000
261 ABDOMINAL PAIN 4 0.0000
262 SURGERY 1 0.0000
263 VOMITING 8 0.0000
264 WHEEZING 1 0.0000
265 ILL-DEFINED DISORDER 1 0.0000
266 FEELING HOT 1 0.0000
267 VISUAL IMPAIRMENT 2 0.0000
268 ASTHENIA 6 0.0000
269 PNEUMONIA 5 0.0000
270 SOMNOLENCE 3 0.0000
271 PAIN 9 0.0000
272 VISION BLURRED 2 0.0000
273 WEIGHT DECREASED 4 0.0000
274 SKIN BURNING SENSATION 1 0.0000
275 AGITATION 1 0.0000
276 PAIN IN EXTREMITY 4 0.0000
277 EPISTAXIS 1 0.0000
278 HYPOAESTHESIA 2 0.0000
279 HOT FLUSH 1 0.0000
280 CONDITION AGGRAVATED 4 0.0000
281 PERIPHERAL SWELLING 2 0.0000
282 THROMBOSIS 1 0.0000
283 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
284 RENAL IMPAIRMENT 1 0.0000
285 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
286 MALAISE 5 0.0000
287 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
288 CARDIAC DISORDER 1 0.0000
289 DRUG INTOLERANCE 1 0.0000
290 HEART RATE INCREASED 1 0.0000
291 HYPERTENSION 2 0.0000
292 CONSTIPATION 2 0.0000
293 SEPSIS 1 0.0000
294 RHEUMATOID ARTHRITIS 1 0.0000
295 MUSCULAR WEAKNESS 1 0.0000
296 INCORRECT DOSE ADMINISTERED 2 0.0000
297 JOINT SWELLING 1 0.0000
298 EMOTIONAL DISTRESS 1 0.0000
299 INJECTION SITE ERYTHEMA 1 0.0000
300 LOSS OF CONSCIOUSNESS 1 0.0000
301 DIARRHOEA 5 0.0000
302 DEHYDRATION 1 0.0000
303 MEMORY IMPAIRMENT 1 0.0000
304 ARTHRALGIA 3 0.0000
305 DRUG INEFFECTIVE 8 0.0000
306 CEREBROVASCULAR ACCIDENT 1 0.0000
307 BLOOD GLUCOSE INCREASED 1 0.0000
308 ANAEMIA 1 0.0000
309 ALOPECIA 1 0.0000
310 DEATH 4 0.0000
311 WEIGHT INCREASED 1 0.0000
312 DEPRESSION 1 0.0000
313 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
314 INJECTION SITE PAIN 1 0.0000
315 FALL 1 0.0000